Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference
Jun/110
ROCKVILLE, Md., May 25, 2011 — Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in New York on Tuesday, June 7, 2011 at 1:15 PM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate overview, which may include a discussion of the company’s business activities and financial performance.
A webcast of this presentation will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors”.
About Emergent BioSolutions Inc.
Emergent BioSolutions, led by Chairman and CEO Fuad El-Hibri, protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent’s marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at www.emergentbiosolutions.com.
SOURCE: Emergent BioSolutions Inc.
Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference
Apr/110
Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the 10th Annual Needham & Company Healthcare Conference in New York on Tuesday, April 5, 2011 at 8:00 AM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate overview, which may include a discussion of recent business developments, 2010 financial results and financial guidance for 2011.
A webcast of this presentation will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors”.
About Emergent BioSolutions Inc.
Emergent BioSolutions, led by Chairman and CEO, Fuad El-Hibri, protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent’s marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at www.emergentbiosolutions.com.
The El-Hibri Foundation Launches Website
Jul/100
The El-Hibri Foundation is a nonprofit organization with the goal of fostering dialogue between various religions and encouraging nonviolent solutions to global challenges affecting humankind. The Foundation has a new website at www.elhibrifoundation.org.
The Foundation, lead by Chairman of the Board of Trustees Fuad El-HIbri, is divided into four different initiatives: The Peace Education Initiative, The Interfaith Dialogue Initiative, The Humanitarian Aid Initiative, and The Social Justice Initiative.
Fuad El-Hibri awards the 2009 Peace Education award
The Peace Education Initiative focuses on conflict resolution, embracing cultural diversity, and supporting cross-cultural approaches to peace-building. The Interfaith Dialogue Initiative focuses on supporting understanding between the three Abrahamic faiths: Islam, Judaism and Christianity. The Humanitarian Aid Initiative provides grants to organizations that aim at delivering education and medical care to the disadvantaged. The last of the four initiatives is the Social Justice Initiative. The Social Justice Initiative addresses issues of equality, justice and human rights, especially for women and children.
The El-Hibri Foundation promotes these four initiatives through the provision of grants. Since its creation in 2001, the Foundation has given away 36 grants totaling over 8.2 million dollars.
For more information on the El-Hibri Foundation visit their website: www.elhibrifoundation.org
Emergent BioSolutions to Participate in June 2010 Investor Conferences
Jun/100
Fuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the company will be participating in the following investor conferences during June 2010:
- The Jefferies & Company 2010 Global Life Sciences Conference
New York, NY.
June 8, 2010
Corporate Overview Presentation
11:00 AM Eastern
There will be a full webcast with slides that will include discussion of the Company’s business activities, financial outlook and current news.
- The Needham & Company 9th Annual Healthcare Conference
New York, NY.
June 10, 2010
Corporate Overview Presentation
3:20 PM Eastern
There will be a full webcast with slides that will include discussion of the Company’s business activities, financial outlook and current news.
Both webcasts will be accessible from the Emergent website www.emergentbiosolutions.com under “Investors”.